{"id":"https://openalex.org/W4362482280","doi":"https://doi.org/10.1158/1535-7163.22506100","title":"Supplementary Figure 2 - Cell viability assay for pediatric brain tumour lines exposed to the indicated concentrations of Veliparib, Olaparib, or Niraparib. from Poly-ADP-Ribose Polymerase as a Therapeutic Target in Pediatric Diffuse Intrinsic Pontine Glioma and Pediatric High-Grade Astrocytoma","display_name":"Supplementary Figure 2 - Cell viability assay for pediatric brain tumour lines exposed to the indicated concentrations of Veliparib, Olaparib, or Niraparib. from Poly-ADP-Ribose Polymerase as a Therapeutic Target in Pediatric Diffuse Intrinsic Pontine Glioma and Pediatric High-Grade Astrocytoma","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362482280","doi":"https://doi.org/10.1158/1535-7163.22506100"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.22506100","doi":"https://doi.org/10.1158/1535-7163.22506100","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22506100","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1535-7163.22506100","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039370854","display_name":"Yevgen Chornenkyy","orcid":"https://orcid.org/0000-0001-5817-3236","observed_orcids":["https://orcid.org/0000-0001-5817-3236"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yevgen Chornenkyy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056492340","display_name":"Sameer Agnihotri","orcid":"https://orcid.org/0000-0001-6584-3795","observed_orcids":["https://orcid.org/0000-0001-6584-3795"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sameer Agnihotri","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101732141","display_name":"Man Yu","orcid":"https://orcid.org/0000-0003-2777-3620","observed_orcids":["https://orcid.org/0000-0003-2777-3620"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Man Yu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013452761","display_name":"Pawel Buczkowicz","orcid":"https://orcid.org/0000-0002-6469-1475","observed_orcids":["https://orcid.org/0000-0002-6469-1475"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pawel Buczkowicz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017368198","display_name":"Patricia Rakopoulos","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patricia Rakopoulos","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017136932","display_name":"Brian J. Golbourn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brian Golbourn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016627721","display_name":"Livia Garzia","orcid":"https://orcid.org/0000-0002-5016-0753","observed_orcids":["https://orcid.org/0000-0002-5016-0753"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Livia Garzia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061265510","display_name":"Robert Siddaway","orcid":"https://orcid.org/0000-0003-2013-9467","observed_orcids":["https://orcid.org/0000-0003-2013-9467"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert Siddaway","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060830603","display_name":"Stephie Leung","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephie Leung","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067215084","display_name":"James T. Rutka","orcid":"https://orcid.org/0000-0003-0851-7330","observed_orcids":["https://orcid.org/0000-0003-0851-7330"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James T. Rutka","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100644772","display_name":"Michael D. Taylor","orcid":"https://orcid.org/0000-0001-7009-3466","observed_orcids":["https://orcid.org/0000-0001-7009-3466","https://orcid.org/0009-0001-7181-1906"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael D. Taylor","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062426776","display_name":"Peter B. Dirks","orcid":"https://orcid.org/0000-0001-5718-6465","observed_orcids":["https://orcid.org/0000-0001-5718-6465"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter B. Dirks","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5068881416","display_name":"Cynthia E Hawkins","orcid":"https://orcid.org/0000-0003-2618-4402","observed_orcids":["https://orcid.org/0000-0003-2618-4402","https://orcid.org/0000-0001-6614-5171"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cynthia Hawkins","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.9330000281333923},{"id":"https://openalex.org/keywords/veliparib","display_name":"veliparib","score":0.828000009059906},{"id":"https://openalex.org/keywords/olaparib","display_name":"olaparib","score":1.0},{"id":"https://openalex.org/keywords/niraparib","display_name":"niraparib","score":1.0},{"id":"https://openalex.org/keywords/pediatric-brain-tumors","display_name":"pediatric brain tumors","score":0.7149999737739563},{"id":"https://openalex.org/keywords/diffuse-intrinsic-pontine-glioma","display_name":"diffuse intrinsic pontine glioma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/high-grade-astrocytoma","display_name":"high-grade astrocytoma","score":0.9330000281333923},{"id":"https://openalex.org/keywords/cell-viability","display_name":"cell viability","score":0.8579999804496765},{"id":"https://openalex.org/keywords/ic50","display_name":"IC50","score":0.8309999704360962}],"concepts":[{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.8486659526824951},{"id":"https://openalex.org/C2779962180","wikidata":"https://www.wikidata.org/wiki/Q7083106","display_name":"Olaparib","level":5,"score":0.7235656976699829},{"id":"https://openalex.org/C2781312401","wikidata":"https://www.wikidata.org/wiki/Q7919041","display_name":"Veliparib","level":5,"score":0.6679874658584595},{"id":"https://openalex.org/C2780783641","wikidata":"https://www.wikidata.org/wiki/Q738686","display_name":"MTT assay","level":3,"score":0.6167652010917664},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.530235767364502},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.5270531177520752},{"id":"https://openalex.org/C2776415932","wikidata":"https://www.wikidata.org/wiki/Q48743","display_name":"Western blot","level":3,"score":0.4662403464317322},{"id":"https://openalex.org/C2778480876","wikidata":"https://www.wikidata.org/wiki/Q21112674","display_name":"PARP1","level":5,"score":0.45481857657432556},{"id":"https://openalex.org/C2779138821","wikidata":"https://www.wikidata.org/wiki/Q7118227","display_name":"PARP inhibitor","level":5,"score":0.41526609659194946},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3878313899040222},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.37470558285713196},{"id":"https://openalex.org/C16685009","wikidata":"https://www.wikidata.org/wiki/Q335057","display_name":"Andrology","level":1,"score":0.3440277576446533},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.32442769408226013},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.3118990957736969},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.30978646874427795},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.15425938367843628},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.09980511665344238},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1535-7163.22506100","doi":"https://doi.org/10.1158/1535-7163.22506100","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22506100","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1535-7163.22506100.v1","doi":"https://doi.org/10.1158/1535-7163.22506100.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22506100.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.22506100","doi":"https://doi.org/10.1158/1535-7163.22506100","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22506100","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4362493043","https://openalex.org/W2226081785","https://openalex.org/W7014494878","https://openalex.org/W2319395988","https://openalex.org/W2320960596","https://openalex.org/W2035566238","https://openalex.org/W4281924026","https://openalex.org/W4361884101","https://openalex.org/W2031593291","https://openalex.org/W4361944932"],"abstract_inverted_index":{"A,":[0],"MTT":[1,41,69,95],"cell":[2,9,34,42,62,88],"viability":[3,35,43,70,96],"relative":[4,36,57,83],"absorbance":[5],"values":[6,66,92],"across":[7,60,86],"multiple":[8],"lines":[10,63,89],"after":[11],"a":[12],"7-day":[13],"incubation":[14],"with":[15,21,46],"Veliparib,":[16],"Olaparib,":[17],"or":[18],"Niraparib.":[19],"Boxes":[20],"an":[22,26],"asterisk":[23],"denote":[24],"that":[25],"indicated":[27],"concentration":[28],"of":[29,104,126],"PARP":[30],"inhibitor":[31],"significantly":[32],"reduced":[33],"vehicle":[37],"treated":[38],"cells.":[39],"B,":[40],"heat":[44],"map":[45],"numerical":[47],"values.":[48],"C,":[49],"Linear":[50,76],"regression":[51,77],"analysis":[52,78],"between":[53,79],"PARP1":[54,80,105,117],"protein":[55,118],"levels,":[56,82],"to":[58,84],"GAPDH,":[59,85],"all":[61,87],"vs.":[64,90],"IC50":[65,91],"calculated":[67,93],"from":[68,94],"assay":[71,97],"on":[72,98],"day":[73,99],"7.":[74,100],"D,":[75],"activity":[81],"E,":[101],"Different":[102],"exposure":[103],"Western":[106],"blot":[107],"in":[108],"SJG2,":[109],"SF188,":[110],"462,":[111],"and":[112],"626":[113],"cells":[114],"demonstrating":[115],"variable":[116],"expression.":[119],"*,":[120],"**,":[121],"***,":[122],"****":[123],"Denotes":[124],"significance":[125],"p<0.05,":[127],"p<0.01,":[128],"p<0.001,":[129],"p<0.0001,":[130],"respectively.":[131],"Error":[132],"bars":[133],"represent":[134],"SEM.":[135]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}